nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—MAPK3—hematologic cancer	0.124	0.284	CbGaD
Arsenic trioxide—CCND1—hematologic cancer	0.116	0.267	CbGaD
Arsenic trioxide—JUN—hematologic cancer	0.101	0.231	CbGaD
Arsenic trioxide—AKT1—hematologic cancer	0.0809	0.186	CbGaD
Arsenic trioxide—JUN—Vinblastine—hematologic cancer	0.0599	0.166	CbGbCtD
Arsenic trioxide—CYP1B1—Procarbazine—hematologic cancer	0.0417	0.116	CbGbCtD
Arsenic trioxide—CYP1B1—Daunorubicin—hematologic cancer	0.0223	0.062	CbGbCtD
Arsenic trioxide—ABCB1—hematologic cancer	0.0141	0.0324	CbGaD
Arsenic trioxide—CYP1B1—Dasatinib—hematologic cancer	0.0137	0.0381	CbGbCtD
Arsenic trioxide—CYP1B1—Mitoxantrone—hematologic cancer	0.0136	0.0377	CbGbCtD
Arsenic trioxide—ABCC2—Daunorubicin—hematologic cancer	0.0117	0.0326	CbGbCtD
Arsenic trioxide—CYP1A1—Methoxsalen—hematologic cancer	0.0108	0.0299	CbGbCtD
Arsenic trioxide—CYP1A1—Bortezomib—hematologic cancer	0.0102	0.0284	CbGbCtD
Arsenic trioxide—CYP1A1—Daunorubicin—hematologic cancer	0.0098	0.0272	CbGbCtD
Arsenic trioxide—CYP1A1—Thalidomide—hematologic cancer	0.00893	0.0248	CbGbCtD
Arsenic trioxide—CYP1A1—Dacarbazine—hematologic cancer	0.00768	0.0213	CbGbCtD
Arsenic trioxide—CYP1B1—Dexamethasone—hematologic cancer	0.00704	0.0195	CbGbCtD
Arsenic trioxide—ABCB1—Lenalidomide—hematologic cancer	0.00653	0.0181	CbGbCtD
Arsenic trioxide—CYP1A1—Dasatinib—hematologic cancer	0.00603	0.0167	CbGbCtD
Arsenic trioxide—CYP1B1—Doxorubicin—hematologic cancer	0.00584	0.0162	CbGbCtD
Arsenic trioxide—ABCC2—Irinotecan—hematologic cancer	0.00562	0.0156	CbGbCtD
Arsenic trioxide—ABCC2—Vinblastine—hematologic cancer	0.005	0.0139	CbGbCtD
Arsenic trioxide—ABCC2—Vincristine—hematologic cancer	0.00491	0.0136	CbGbCtD
Arsenic trioxide—ABCC2—Cisplatin—hematologic cancer	0.00458	0.0127	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—hematologic cancer	0.0045	0.0125	CbGbCtD
Arsenic trioxide—CYP3A4—Bexarotene—hematologic cancer	0.00391	0.0109	CbGbCtD
Arsenic trioxide—ABCB1—Daunorubicin—hematologic cancer	0.00383	0.0106	CbGbCtD
Arsenic trioxide—ABCB1—Alitretinoin—hematologic cancer	0.00375	0.0104	CbGbCtD
Arsenic trioxide—ABCC2—Dexamethasone—hematologic cancer	0.0037	0.0103	CbGbCtD
Arsenic trioxide—CYP3A4—Busulfan—hematologic cancer	0.00364	0.0101	CbGbCtD
Arsenic trioxide—CYP3A4—Lomustine—hematologic cancer	0.00364	0.0101	CbGbCtD
Arsenic trioxide—CYP3A4—Thiotepa—hematologic cancer	0.00324	0.009	CbGbCtD
Arsenic trioxide—CYP1A1—Dexamethasone—hematologic cancer	0.00309	0.00857	CbGbCtD
Arsenic trioxide—ABCC2—Doxorubicin—hematologic cancer	0.00307	0.00852	CbGbCtD
Arsenic trioxide—ABCC2—Methotrexate—hematologic cancer	0.00297	0.00825	CbGbCtD
Arsenic trioxide—ABCB1—Imatinib—hematologic cancer	0.00293	0.00814	CbGbCtD
Arsenic trioxide—ABCB1—Nilotinib—hematologic cancer	0.00266	0.0074	CbGbCtD
Arsenic trioxide—ABCB1—Vinorelbine—hematologic cancer	0.00264	0.00733	CbGbCtD
Arsenic trioxide—CYP3A4—Methoxsalen—hematologic cancer	0.00252	0.007	CbGbCtD
Arsenic trioxide—CYP3A4—Bortezomib—hematologic cancer	0.0024	0.00666	CbGbCtD
Arsenic trioxide—ABCB1—Dasatinib—hematologic cancer	0.00236	0.00654	CbGbCtD
Arsenic trioxide—ABCB1—Mitoxantrone—hematologic cancer	0.00233	0.00646	CbGbCtD
Arsenic trioxide—CYP3A4—Daunorubicin—hematologic cancer	0.00229	0.00637	CbGbCtD
Arsenic trioxide—ABCB1—Betamethasone—hematologic cancer	0.00207	0.00575	CbGbCtD
Arsenic trioxide—ABCB1—Gemcitabine—hematologic cancer	0.00206	0.0057	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—hematologic cancer	0.00205	0.00568	CbGbCtD
Arsenic trioxide—CYP3A4—Cytarabine—hematologic cancer	0.00202	0.00561	CbGbCtD
Arsenic trioxide—CYP3A4—Teniposide—hematologic cancer	0.00199	0.00553	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—hematologic cancer	0.00193	0.00536	CbGbCtD
Arsenic trioxide—CYP3A4—Ifosfamide—hematologic cancer	0.00184	0.0051	CbGbCtD
Arsenic trioxide—ABCB1—Irinotecan—hematologic cancer	0.00183	0.00508	CbGbCtD
Arsenic trioxide—CYP3A4—Imatinib—hematologic cancer	0.00176	0.00488	CbGbCtD
Arsenic trioxide—CCND1—hematopoietic system—hematologic cancer	0.00166	0.0377	CbGeAlD
Arsenic trioxide—CYP3A4—Ruxolitinib—hematologic cancer	0.00165	0.00459	CbGbCtD
Arsenic trioxide—ABCB1—Vinblastine—hematologic cancer	0.00163	0.00452	CbGbCtD
Arsenic trioxide—ABCB1—Vincristine—hematologic cancer	0.0016	0.00444	CbGbCtD
Arsenic trioxide—CYP3A4—Nilotinib—hematologic cancer	0.0016	0.00443	CbGbCtD
Arsenic trioxide—CYP3A4—Vinorelbine—hematologic cancer	0.00158	0.00439	CbGbCtD
Arsenic trioxide—ABCB1—Cisplatin—hematologic cancer	0.00149	0.00414	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—hematologic cancer	0.00147	0.00407	CbGbCtD
Arsenic trioxide—CYP3A4—Triamcinolone—hematologic cancer	0.00145	0.00402	CbGbCtD
Arsenic trioxide—CYP3A4—Dasatinib—hematologic cancer	0.00141	0.00392	CbGbCtD
Arsenic trioxide—MAPK1—hematopoietic system—hematologic cancer	0.0014	0.0317	CbGeAlD
Arsenic trioxide—CYP3A4—Mitoxantrone—hematologic cancer	0.00139	0.00387	CbGbCtD
Arsenic trioxide—TXNRD1—hematopoietic system—hematologic cancer	0.0013	0.0295	CbGeAlD
Arsenic trioxide—CCND1—gonad—hematologic cancer	0.00126	0.0286	CbGeAlD
Arsenic trioxide—CYP3A4—Betamethasone—hematologic cancer	0.00124	0.00345	CbGbCtD
Arsenic trioxide—MAPK3—hematopoietic system—hematologic cancer	0.00124	0.0281	CbGeAlD
Arsenic trioxide—CYP3A4—Prednisolone—hematologic cancer	0.00123	0.0034	CbGbCtD
Arsenic trioxide—ABCB1—Dexamethasone—hematologic cancer	0.00121	0.00335	CbGbCtD
Arsenic trioxide—AKT1—hematopoietic system—hematologic cancer	0.00117	0.0265	CbGeAlD
Arsenic trioxide—CYP3A4—Prednisone—hematologic cancer	0.00116	0.00321	CbGbCtD
Arsenic trioxide—CCND1—blood—hematologic cancer	0.0011	0.025	CbGeAlD
Arsenic trioxide—CYP3A4—Irinotecan—hematologic cancer	0.0011	0.00305	CbGbCtD
Arsenic trioxide—MAPK1—gonad—hematologic cancer	0.00106	0.0241	CbGeAlD
Arsenic trioxide—JUN—hematopoietic system—hematologic cancer	0.00102	0.0231	CbGeAlD
Arsenic trioxide—IKBKB—hematopoietic system—hematologic cancer	0.00101	0.0229	CbGeAlD
Arsenic trioxide—ABCB1—Doxorubicin—hematologic cancer	0.001	0.00278	CbGbCtD
Arsenic trioxide—TXNRD1—gonad—hematologic cancer	0.000989	0.0225	CbGeAlD
Arsenic trioxide—CYP3A4—Vinblastine—hematologic cancer	0.000976	0.00271	CbGbCtD
Arsenic trioxide—ABCB1—Methotrexate—hematologic cancer	0.000969	0.00269	CbGbCtD
Arsenic trioxide—CCND1—lung—hematologic cancer	0.000963	0.0219	CbGeAlD
Arsenic trioxide—CYP3A4—Vincristine—hematologic cancer	0.000959	0.00266	CbGbCtD
Arsenic trioxide—MAPK3—gonad—hematologic cancer	0.00094	0.0214	CbGeAlD
Arsenic trioxide—MAPK1—blood—hematologic cancer	0.000926	0.021	CbGeAlD
Arsenic trioxide—CCND1—testis—hematologic cancer	0.000909	0.0206	CbGeAlD
Arsenic trioxide—MAPK1—bone marrow—hematologic cancer	0.000896	0.0203	CbGeAlD
Arsenic trioxide—AKT1—gonad—hematologic cancer	0.000887	0.0201	CbGeAlD
Arsenic trioxide—CYP3A4—Etoposide—hematologic cancer	0.000879	0.00244	CbGbCtD
Arsenic trioxide—TXNRD1—blood—hematologic cancer	0.000862	0.0196	CbGeAlD
Arsenic trioxide—TXNRD1—bone marrow—hematologic cancer	0.000834	0.0189	CbGeAlD
Arsenic trioxide—MAPK3—blood—hematologic cancer	0.000819	0.0186	CbGeAlD
Arsenic trioxide—MAPK1—lung—hematologic cancer	0.000812	0.0184	CbGeAlD
Arsenic trioxide—MAPK3—bone marrow—hematologic cancer	0.000793	0.018	CbGeAlD
Arsenic trioxide—AKT1—blood—hematologic cancer	0.000773	0.0176	CbGeAlD
Arsenic trioxide—JUN—gonad—hematologic cancer	0.000772	0.0175	CbGeAlD
Arsenic trioxide—IKBKB—gonad—hematologic cancer	0.000768	0.0174	CbGeAlD
Arsenic trioxide—MAPK1—testis—hematologic cancer	0.000766	0.0174	CbGeAlD
Arsenic trioxide—TXNRD1—lung—hematologic cancer	0.000755	0.0172	CbGeAlD
Arsenic trioxide—AKT1—bone marrow—hematologic cancer	0.000748	0.017	CbGeAlD
Arsenic trioxide—CYP3A4—Dexamethasone—hematologic cancer	0.000723	0.00201	CbGbCtD
Arsenic trioxide—MAPK3—lung—hematologic cancer	0.000718	0.0163	CbGeAlD
Arsenic trioxide—TXNRD1—testis—hematologic cancer	0.000713	0.0162	CbGeAlD
Arsenic trioxide—MAPK3—testis—hematologic cancer	0.000678	0.0154	CbGeAlD
Arsenic trioxide—AKT1—lung—hematologic cancer	0.000677	0.0154	CbGeAlD
Arsenic trioxide—JUN—blood—hematologic cancer	0.000673	0.0153	CbGeAlD
Arsenic trioxide—IKBKB—blood—hematologic cancer	0.000669	0.0152	CbGeAlD
Arsenic trioxide—CCND1—lymph node—hematologic cancer	0.000659	0.015	CbGeAlD
Arsenic trioxide—JUN—bone marrow—hematologic cancer	0.000651	0.0148	CbGeAlD
Arsenic trioxide—AKT1—testis—hematologic cancer	0.000639	0.0145	CbGeAlD
Arsenic trioxide—CYP3A4—Doxorubicin—hematologic cancer	0.0006	0.00166	CbGbCtD
Arsenic trioxide—JUN—lung—hematologic cancer	0.00059	0.0134	CbGeAlD
Arsenic trioxide—IKBKB—lung—hematologic cancer	0.000587	0.0133	CbGeAlD
Arsenic trioxide—JUN—testis—hematologic cancer	0.000556	0.0126	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—hematologic cancer	0.000555	0.0126	CbGeAlD
Arsenic trioxide—IKBKB—testis—hematologic cancer	0.000554	0.0126	CbGeAlD
Arsenic trioxide—CYP1B1—hematopoietic system—hematologic cancer	0.000541	0.0123	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—hematologic cancer	0.000517	0.0117	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—hematologic cancer	0.000491	0.0112	CbGeAlD
Arsenic trioxide—AKT1—lymph node—hematologic cancer	0.000463	0.0105	CbGeAlD
Arsenic trioxide—CYP1B1—gonad—hematologic cancer	0.000411	0.00935	CbGeAlD
Arsenic trioxide—JUN—lymph node—hematologic cancer	0.000403	0.00916	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—hematologic cancer	0.000401	0.00912	CbGeAlD
Arsenic trioxide—CYP1A1—hematopoietic system—hematologic cancer	0.000383	0.00869	CbGeAlD
Arsenic trioxide—CCND1—Ponatinib—Nilotinib—hematologic cancer	0.000381	0.139	CbGdCrCtD
Arsenic trioxide—ABCC2—blood—hematologic cancer	0.000366	0.00832	CbGeAlD
Arsenic trioxide—CYP1B1—blood—hematologic cancer	0.000359	0.00814	CbGeAlD
Arsenic trioxide—CYP1B1—lung—hematologic cancer	0.000314	0.00714	CbGeAlD
Arsenic trioxide—ABCC2—testis—hematologic cancer	0.000303	0.00688	CbGeAlD
Arsenic trioxide—CYP1B1—testis—hematologic cancer	0.000297	0.00674	CbGeAlD
Arsenic trioxide—CCND1—Ponatinib—Imatinib—hematologic cancer	0.000288	0.105	CbGdCrCtD
Arsenic trioxide—CYP3A4—hematopoietic system—hematologic cancer	0.000281	0.00638	CbGeAlD
Arsenic trioxide—CYP1A1—blood—hematologic cancer	0.000253	0.00576	CbGeAlD
Arsenic trioxide—CYP1A1—lung—hematologic cancer	0.000222	0.00505	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—hematologic cancer	0.00022	0.00499	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—hematologic cancer	0.000215	0.00488	CbGeAlD
Arsenic trioxide—ABCB1—hematopoietic system—hematologic cancer	0.000199	0.00451	CbGeAlD
Arsenic trioxide—CYP3A4—blood—hematologic cancer	0.000186	0.00422	CbGeAlD
Arsenic trioxide—TXNRD1—Topotecan—Irinotecan—hematologic cancer	0.000179	0.0651	CbGdCrCtD
Arsenic trioxide—AKT1—Tretinoin—Alitretinoin—hematologic cancer	0.000158	0.0574	CbGdCrCtD
Arsenic trioxide—AKT1—Isotretinoin—Alitretinoin—hematologic cancer	0.000158	0.0574	CbGdCrCtD
Arsenic trioxide—CYP1A1—lymph node—hematologic cancer	0.000152	0.00345	CbGeAlD
Arsenic trioxide—ABCB1—gonad—hematologic cancer	0.000151	0.00343	CbGeAlD
Arsenic trioxide—ABCB1—blood—hematologic cancer	0.000132	0.00299	CbGeAlD
Arsenic trioxide—ABCB1—bone marrow—hematologic cancer	0.000127	0.00289	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Daunorubicin—hematologic cancer	0.000121	0.044	CbGdCrCtD
Arsenic trioxide—ABCB1—lung—hematologic cancer	0.000115	0.00262	CbGeAlD
Arsenic trioxide—ABCB1—testis—hematologic cancer	0.000109	0.00247	CbGeAlD
Arsenic trioxide—TXNRD1—Daunorubicin—Idarubicin—hematologic cancer	9.16e-05	0.0333	CbGdCrCtD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—hematologic cancer	8.06e-05	0.0294	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Pentostatin—hematologic cancer	8.04e-05	0.0293	CbGdCrCtD
Arsenic trioxide—ABCB1—lymph node—hematologic cancer	7.89e-05	0.00179	CbGeAlD
Arsenic trioxide—CCND1—Azacitidine—Clofarabine—hematologic cancer	7.17e-05	0.0261	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Nelarabine—hematologic cancer	6.74e-05	0.0245	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Pentostatin—hematologic cancer	6.09e-05	0.0222	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Clofarabine—hematologic cancer	5.43e-05	0.0198	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Fludarabine—hematologic cancer	5.26e-05	0.0192	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Nelarabine—hematologic cancer	5.11e-05	0.0186	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Cytarabine—hematologic cancer	4.97e-05	0.0181	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Gemcitabine—hematologic cancer	4.97e-05	0.0181	CbGdCrCtD
Arsenic trioxide—CCND1—Azacitidine—Cladribine—hematologic cancer	4.84e-05	0.0176	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Epirubicin—hematologic cancer	4.2e-05	0.0153	CbGdCrCtD
Arsenic trioxide—TXNRD1—Idarubicin—Epirubicin—hematologic cancer	4.2e-05	0.0153	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Fludarabine—hematologic cancer	3.99e-05	0.0145	CbGdCrCtD
Arsenic trioxide—TXNRD1—Idarubicin—Doxorubicin—hematologic cancer	3.89e-05	0.0142	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Doxorubicin—hematologic cancer	3.89e-05	0.0142	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Cytarabine—hematologic cancer	3.77e-05	0.0137	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Gemcitabine—hematologic cancer	3.77e-05	0.0137	CbGdCrCtD
Arsenic trioxide—AKT1—Azacitidine—Cladribine—hematologic cancer	3.67e-05	0.0134	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Betamethasone—hematologic cancer	1.98e-05	0.00719	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Dexamethasone—hematologic cancer	1.98e-05	0.00719	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Betamethasone—hematologic cancer	1.95e-05	0.0071	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Dexamethasone—hematologic cancer	1.95e-05	0.0071	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Triamcinolone—hematologic cancer	1.93e-05	0.00703	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.91e-05	0.00694	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Betamethasone—hematologic cancer	1.91e-05	0.00694	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Triamcinolone—hematologic cancer	1.9e-05	0.00694	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Triamcinolone—hematologic cancer	1.9e-05	0.00694	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.86e-05	0.00678	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—hematologic cancer	1.83e-05	0.00667	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisone—hematologic cancer	1.81e-05	0.00658	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—hematologic cancer	1.81e-05	0.00658	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—hematologic cancer	1.79e-05	0.00651	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—hematologic cancer	1.76e-05	0.00643	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—hematologic cancer	1.76e-05	0.00643	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—hematologic cancer	1.69e-05	0.00615	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Dexamethasone—hematologic cancer	9.67e-06	0.00352	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Betamethasone—hematologic cancer	9.67e-06	0.00352	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Triamcinolone—hematologic cancer	9.44e-06	0.00344	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Triamcinolone—hematologic cancer	9.44e-06	0.00344	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—hematologic cancer	8.96e-06	0.00326	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—hematologic cancer	8.96e-06	0.00326	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—hematologic cancer	8.75e-06	0.00319	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—hematologic cancer	8.75e-06	0.00319	CbGdCrCtD
Arsenic trioxide—AKT1—Immune System—KRAS—hematologic cancer	4.31e-07	2.74e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MYC—hematologic cancer	4.31e-07	2.74e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—hematologic cancer	4.3e-07	2.73e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—JAK2—hematologic cancer	4.29e-07	2.73e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAP2K1—hematologic cancer	4.29e-07	2.73e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STAT3—hematologic cancer	4.28e-07	2.72e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NRAS—hematologic cancer	4.27e-07	2.72e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FGF2—hematologic cancer	4.26e-07	2.71e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CD—hematologic cancer	4.26e-07	2.71e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MAPK3—hematologic cancer	4.24e-07	2.69e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.24e-07	2.69e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—PIK3CA—hematologic cancer	4.21e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3CB—hematologic cancer	4.2e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MTOR—hematologic cancer	4.2e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3R1—hematologic cancer	4.2e-07	2.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MDM2—hematologic cancer	4.19e-07	2.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KRAS—hematologic cancer	4.18e-07	2.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MYC—hematologic cancer	4.18e-07	2.66e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CB—hematologic cancer	4.18e-07	2.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—hematologic cancer	4.17e-07	2.65e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—EP300—hematologic cancer	4.14e-07	2.63e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PIK3CA—hematologic cancer	4.13e-07	2.62e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.12e-07	2.62e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.12e-07	2.62e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CDKN1B—hematologic cancer	4.11e-07	2.61e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MAPK3—hematologic cancer	4.09e-07	2.6e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—JAK2—hematologic cancer	4.08e-07	2.6e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MTOR—hematologic cancer	4.08e-07	2.59e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CB—hematologic cancer	4.08e-07	2.59e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGF2—hematologic cancer	4.08e-07	2.59e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—hematologic cancer	4.02e-07	2.56e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3R1—hematologic cancer	4.02e-07	2.56e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—hematologic cancer	4.02e-07	2.55e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.02e-07	2.55e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HRAS—hematologic cancer	4.01e-07	2.55e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PIK3CA—hematologic cancer	4e-07	2.55e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—hematologic cancer	4e-07	2.54e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MDM2—hematologic cancer	3.99e-07	2.54e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KRAS—hematologic cancer	3.98e-07	2.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KRAS—hematologic cancer	3.98e-07	2.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MYC—hematologic cancer	3.98e-07	2.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—hematologic cancer	3.97e-07	2.52e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PIK3CA—hematologic cancer	3.96e-07	2.52e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CDKN1B—hematologic cancer	3.94e-07	2.51e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTP1—hematologic cancer	3.93e-07	2.5e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCND1—hematologic cancer	3.92e-07	2.49e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—JAK2—hematologic cancer	3.91e-07	2.48e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HRAS—hematologic cancer	3.89e-07	2.47e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NUP98—hematologic cancer	3.89e-07	2.47e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MTOR—hematologic cancer	3.88e-07	2.47e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CB—hematologic cancer	3.88e-07	2.47e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—hematologic cancer	3.87e-07	2.46e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KRAS—hematologic cancer	3.86e-07	2.46e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—hematologic cancer	3.86e-07	2.45e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PIK3CA—hematologic cancer	3.84e-07	2.44e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—hematologic cancer	3.84e-07	2.44e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CDKN1B—hematologic cancer	3.83e-07	2.43e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HRAS—hematologic cancer	3.82e-07	2.43e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MDM2—hematologic cancer	3.81e-07	2.43e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KRAS—hematologic cancer	3.81e-07	2.42e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CDKN1A—hematologic cancer	3.79e-07	2.41e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTEN—hematologic cancer	3.78e-07	2.4e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.78e-07	2.4e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.78e-07	2.4e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCND1—hematologic cancer	3.76e-07	2.39e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—JUN—hematologic cancer	3.76e-07	2.39e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—hematologic cancer	3.75e-07	2.38e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NUP214—hematologic cancer	3.75e-07	2.38e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—hematologic cancer	3.74e-07	2.38e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—hematologic cancer	3.73e-07	2.37e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MTOR—hematologic cancer	3.71e-07	2.36e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CB—hematologic cancer	3.71e-07	2.36e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HRAS—hematologic cancer	3.7e-07	2.35e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK8—hematologic cancer	3.7e-07	2.35e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KRAS—hematologic cancer	3.68e-07	2.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTR—hematologic cancer	3.67e-07	2.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.67e-07	2.34e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HRAS—hematologic cancer	3.67e-07	2.33e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PIK3CA—hematologic cancer	3.66e-07	2.33e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PIK3CA—hematologic cancer	3.66e-07	2.33e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—hematologic cancer	3.65e-07	2.32e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCND1—hematologic cancer	3.65e-07	2.32e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—JUN—hematologic cancer	3.64e-07	2.32e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CDKN1A—hematologic cancer	3.64e-07	2.31e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CDKN1B—hematologic cancer	3.64e-07	2.31e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTEN—hematologic cancer	3.63e-07	2.31e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NCOR1—hematologic cancer	3.61e-07	2.3e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—hematologic cancer	3.61e-07	2.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTEN—hematologic cancer	3.61e-07	2.3e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EP300—hematologic cancer	3.61e-07	2.29e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ENO2—hematologic cancer	3.6e-07	2.29e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—hematologic cancer	3.57e-07	2.27e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—hematologic cancer	3.56e-07	2.27e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HRAS—hematologic cancer	3.56e-07	2.26e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK8—hematologic cancer	3.55e-07	2.26e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PIK3CA—hematologic cancer	3.55e-07	2.26e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—hematologic cancer	3.54e-07	2.25e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CDKN1A—hematologic cancer	3.53e-07	2.24e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTEN—hematologic cancer	3.52e-07	2.24e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.52e-07	2.24e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—hematologic cancer	3.51e-07	2.23e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SRC—hematologic cancer	3.51e-07	2.23e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PIK3CA—hematologic cancer	3.5e-07	2.22e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.49e-07	2.22e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CDKN1B—hematologic cancer	3.48e-07	2.21e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCND1—hematologic cancer	3.47e-07	2.21e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—JUN—hematologic cancer	3.47e-07	2.2e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EP300—hematologic cancer	3.46e-07	2.2e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MAPK8—hematologic cancer	3.45e-07	2.19e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—EP300—hematologic cancer	3.44e-07	2.19e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—hematologic cancer	3.44e-07	2.19e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SDC1—hematologic cancer	3.42e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—hematologic cancer	3.41e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—hematologic cancer	3.41e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—hematologic cancer	3.41e-07	2.17e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—hematologic cancer	3.4e-07	2.16e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HRAS—hematologic cancer	3.39e-07	2.15e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HRAS—hematologic cancer	3.38e-07	2.15e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—hematologic cancer	3.38e-07	2.15e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PIK3CA—hematologic cancer	3.38e-07	2.15e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRAS—hematologic cancer	3.37e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—hematologic cancer	3.37e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SRC—hematologic cancer	3.37e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EP300—hematologic cancer	3.36e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CDKN1A—hematologic cancer	3.36e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3.36e-07	2.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTEN—hematologic cancer	3.35e-07	2.13e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCND1—hematologic cancer	3.32e-07	2.11e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—JUN—hematologic cancer	3.32e-07	2.11e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HRAS—hematologic cancer	3.28e-07	2.09e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—hematologic cancer	3.28e-07	2.09e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MAPK8—hematologic cancer	3.28e-07	2.08e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—hematologic cancer	3.27e-07	2.08e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SRC—hematologic cancer	3.27e-07	2.08e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—hematologic cancer	3.25e-07	2.07e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRAS—hematologic cancer	3.24e-07	2.06e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—hematologic cancer	3.24e-07	2.06e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—hematologic cancer	3.24e-07	2.06e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HRAS—hematologic cancer	3.24e-07	2.06e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK3—hematologic cancer	3.23e-07	2.05e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CDKN1A—hematologic cancer	3.21e-07	2.04e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTEN—hematologic cancer	3.21e-07	2.04e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EP300—hematologic cancer	3.2e-07	2.03e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—hematologic cancer	3.19e-07	2.03e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—hematologic cancer	3.18e-07	2.02e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—hematologic cancer	3.15e-07	2e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRAS—hematologic cancer	3.14e-07	2e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—hematologic cancer	3.14e-07	2e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MYC—hematologic cancer	3.14e-07	2e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—hematologic cancer	3.14e-07	2e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK8—hematologic cancer	3.14e-07	1.99e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—hematologic cancer	3.13e-07	1.99e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HRAS—hematologic cancer	3.12e-07	1.99e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—hematologic cancer	3.12e-07	1.99e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CREBBP—hematologic cancer	3.11e-07	1.98e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SRC—hematologic cancer	3.11e-07	1.98e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK3—hematologic cancer	3.1e-07	1.97e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—hematologic cancer	3.1e-07	1.97e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PIK3CA—hematologic cancer	3.06e-07	1.95e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EP300—hematologic cancer	3.06e-07	1.94e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—hematologic cancer	3.03e-07	1.93e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MYC—hematologic cancer	3.02e-07	1.92e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—hematologic cancer	3.01e-07	1.91e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—hematologic cancer	3e-07	1.91e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRAS—hematologic cancer	2.99e-07	1.9e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—hematologic cancer	2.99e-07	1.9e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—hematologic cancer	2.99e-07	1.9e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SRC—hematologic cancer	2.97e-07	1.89e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.95e-07	1.88e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MYC—hematologic cancer	2.93e-07	1.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—hematologic cancer	2.92e-07	1.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—hematologic cancer	2.91e-07	1.85e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CD44—hematologic cancer	2.9e-07	1.85e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.9e-07	1.85e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KRAS—hematologic cancer	2.9e-07	1.85e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—hematologic cancer	2.9e-07	1.84e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—hematologic cancer	2.9e-07	1.84e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—hematologic cancer	2.87e-07	1.82e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MAPK3—hematologic cancer	2.86e-07	1.82e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRAS—hematologic cancer	2.86e-07	1.82e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—hematologic cancer	2.86e-07	1.82e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KRAS—hematologic cancer	2.79e-07	1.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.79e-07	1.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MYC—hematologic cancer	2.79e-07	1.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—hematologic cancer	2.78e-07	1.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—hematologic cancer	2.76e-07	1.75e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.75e-07	1.75e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK3—hematologic cancer	2.74e-07	1.74e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.73e-07	1.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KRAS—hematologic cancer	2.71e-07	1.72e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.68e-07	1.71e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PIK3CA—hematologic cancer	2.67e-07	1.7e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MYC—hematologic cancer	2.67e-07	1.69e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—hematologic cancer	2.66e-07	1.69e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—hematologic cancer	2.58e-07	1.64e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KRAS—hematologic cancer	2.57e-07	1.64e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.57e-07	1.64e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3CA—hematologic cancer	2.56e-07	1.63e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CA—hematologic cancer	2.55e-07	1.62e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CREBBP—hematologic cancer	2.49e-07	1.58e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CA—hematologic cancer	2.49e-07	1.58e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—hematologic cancer	2.48e-07	1.58e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HRAS—hematologic cancer	2.47e-07	1.57e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KRAS—hematologic cancer	2.46e-07	1.57e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.42e-07	1.54e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—hematologic cancer	2.4e-07	1.53e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HRAS—hematologic cancer	2.37e-07	1.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CA—hematologic cancer	2.36e-07	1.5e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—hematologic cancer	2.36e-07	1.5e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.36e-07	1.5e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—hematologic cancer	2.33e-07	1.48e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HRAS—hematologic cancer	2.3e-07	1.46e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.29e-07	1.46e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—hematologic cancer	2.29e-07	1.45e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—hematologic cancer	2.27e-07	1.44e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CA—hematologic cancer	2.26e-07	1.44e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.23e-07	1.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.23e-07	1.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.23e-07	1.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTEN—hematologic cancer	2.22e-07	1.41e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—hematologic cancer	2.2e-07	1.4e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—hematologic cancer	2.19e-07	1.39e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HRAS—hematologic cancer	2.19e-07	1.39e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—hematologic cancer	2.18e-07	1.39e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—EP300—hematologic cancer	2.12e-07	1.35e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—hematologic cancer	2.09e-07	1.33e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HRAS—hematologic cancer	2.09e-07	1.33e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—hematologic cancer	2.08e-07	1.32e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.06e-07	1.31e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—hematologic cancer	2.03e-07	1.29e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—hematologic cancer	2e-07	1.27e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.97e-07	1.25e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—hematologic cancer	1.93e-07	1.23e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—hematologic cancer	1.85e-07	1.18e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTEN—hematologic cancer	1.78e-07	1.13e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—EP300—hematologic cancer	1.69e-07	1.08e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.65e-07	1.05e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.57e-07	9.97e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.53e-07	9.74e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.45e-07	9.24e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—hematologic cancer	1.43e-07	9.12e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.37e-07	8.72e-07	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—hematologic cancer	1.28e-07	8.15e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.27e-07	8.05e-07	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.25e-07	7.97e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.09e-07	6.96e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—EP300—hematologic cancer	1.04e-07	6.64e-07	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—hematologic cancer	1.02e-07	6.51e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.72e-08	4.91e-07	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—hematologic cancer	6.31e-08	4.01e-07	CbGpPWpGaD
